Amarin Corp Plc (AMRN)

[HDGabor]

M-

Both …

50% of eligible people on statin and / due to (from memory):
- wasn't offered / prescribed by a doctor
- 10% denied
- 30-35% stop after a short period

The board is talking about 40 million statin users … it is true … BUT it is app. (max.) 20 million ANNUALIZED patient, since the average usage is app 6 months … like in case of Vascepa.

The requested indication:
- on statin (see above: 20 million annualized)
BUT / PLUS
- TG 135 or higher and additional risk factor

It is app. 7.5 million POTENTIAL patient

If EVERYBODY who is eligible (match to the indication) will be on V = 11.25 bn Net Revenue per year

If the same % as statin (50%) will be on V = 5.62 bn Net Revenue per year

I am not aware of any drug that was prescribed to EVERY eligible patient … 10 bn (US) Net Revenue is a wet dream.

"easily see 15M or more eventually being prescribed Vascepa" could be seen in states where marijuana was legalized … or anywhere but only with a pipe ...

Best,
G